Sylas Pharma Solutions Private Limited
About Sylas Pharma Solutions Private Limited
Data last updated:
Sylas Pharma Solutions Private Limited is a private limited company based in Delhi, India. It operates in the online retail and e-commerce segment of the e-commerce sector. It was incorporated on 31 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52520DL2019PTC359564. Its GSTIN is 07ABDCS1693Q1ZN (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10,000. It is led by directors Imran Alam and Mohammad Shadab Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H 30 S/F Abul Fazal Enclave – 1 Jamia Nagar Okhla New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.72 Lakh. For the same year it recorded a net loss of ₹213 (net margin 0%) and EBITDA of ₹50 (EBITDA margin 0%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH 30 S/F Abul Fazal Enclave – 1 Jamia Nagar Okhla New Delhi, Delhi, India – 110025
- IndustryE-Commerce, Online Store, Retailers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sylas Pharma Solutions Private Limited
The main business activity of Sylas Pharma Solutions is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sylas Pharma Solutions Private Limited FY 2025 filings available
Sylas Pharma Solutions Private Limited reported revenue of ₹5.72 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR) of Sylas Pharma Solutions Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 10% over three years. EBITDA rose 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sylas Pharma Solutions Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹50 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹213 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sylas Pharma Solutions Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sylas Pharma Solutions are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Sylas Pharma Solutions Private Limited
Sylas Pharma Solutions has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Imran Alam | Director | 31 Dec 2019 | 6 Years 9 Months | Current |
| Mohammad Shadab Khan Also directs: Deniz Life Science Private Limited | Director | 31 Dec 2019 | 6 Years 9 Months | Current |
Peer Comparison of Sylas Pharma Solutions Private Limited
Sylas Pharma Solutions Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Umong Ayurveda Private Limited | ₹5.74 Lakh (FY 2025) | •••• | •••• | •••• | Nizamabad, Telangana, India | |
| Raigreen Industries Private Limited | ₹5.74 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Raipur, Chhattisgarh, India |
| Kishni-Safal Farmer Producer Company Limited | ₹5.73 Lakh (FY 2024) | •••• | •••• | •••• | Bhongaon, Uttar Pradesh, India | |
| Crop Day Enterprises Private Limited | ₹5.73 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Salem, Tamil Nadu, India |
| Sylas Pharma Solutions Private Limited this company | ₹5.72 Lakh (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Zionark Technologies Private Limited | ₹5.72 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| S.Kamalpandit Green Farmer Producer Company Limited | ₹5.71 Lakh (FY 2025) | •••• | •••• | -81.0% | •••• | Nanded, Maharashtra, India |
| Galaxy Remedies Private Limited | ₹5.7 Lakh (FY 2025) | •••• | •••• | -36.0% | •••• | Hooghly, West Bengal, India |
| Leela Carpet Private Limited | ₹5.7 Lakh (FY 2025) | •••• | •••• | 22.0% | •••• | New Delhi, Delhi, India |
| RVRH Electrotech Private Limited | ₹5.69 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Tridev Securities Private Limited | ₹5.69 Lakh (FY 2025) | •••• | •••• | -96.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Sylas Pharma Solutions by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Sylas Pharma Solutions Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sylas Pharma Solutions Private Limited
Sylas Pharma Solutions Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Sylas Pharma Solutions Private Limited
Employment history and EPFO contributions of people linked to Sylas Pharma Solutions.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sylas Pharma Solutions Private Limited
Sylas Pharma Solutions Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Imran Alam was appointed as Director on 31 Dec 2019.
Credit Ratings, Litigation & Regulatory Alerts for Sylas Pharma Solutions Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sylas Pharma Solutions Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sylas Pharma Solutions Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sylas Pharma Solutions Private Limited
Sylas Pharma Solutions has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABDCS1693Q1ZN | Delhi | Active | 08 Jan 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sylas Pharma Solutions Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sylas Pharma Solutions Private Limited
Sylas Pharma Solutions is an active private limited company based in Delhi, India. The company works in online store, within the e-commerce industry. It was incorporated on 31 December 2019 (7+ years old) and is registered under CIN U52520DL2019PTC359564.
Sylas Pharma Solutions reported revenue of ₹5.72 Lakh for FY 2025.
Sylas Pharma Solutions has 2 current directors:
- Imran Alam - Director
- Mohammad Shadab Khan - Director
Sylas Pharma Solutions reported a net loss of ₹213 (net margin 0%) and EBITDA of ₹50 (EBITDA margin 0%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sylas Pharma Solutions is 10% over three years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sylas Pharma Solutions is 07ABDCS1693Q1ZN, registered in Delhi.
The CIN (Corporate Identification Number) of Sylas Pharma Solutions is U52520DL2019PTC359564. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sylas Pharma Solutions was incorporated on 31 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sylas Pharma Solutions by revenue are Umong Ayurveda Private Limited, Raigreen Industries Private Limited, Kishni-Safal Farmer Producer Company Limited, Crop Day Enterprises Private Limited, Zionark Technologies Private Limited and 5 more, all in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles).
Imran Alam was appointed as Director on 31 Dec 2019. Mohammad Shadab Khan was appointed as Director on 31 Dec 2019.
The registered office of Sylas Pharma Solutions is at H 30 SF Abul Fazal Enclave – 1 Jamia Nagar Okhla New Delhi, Delhi, India – 110025.